We hereby inform that the Hon'ble National Company Law Tribunal ( NCLT ), Chandigarh Bench has vide its order dated July 17, 2025 approved the Scheme of Arrangement for Amalgamation of Ind-Swift Limited with Ind Swift Laboratories Limited.
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The National Company Law Tribunal (NCLT), Chandigarh Bench, has approved the Scheme of Arrangement for the amalgamation of Ind-Swift Limited (Transferor Company) with Ind-Swift Laboratories Limited (Transferee Company) under Sections 230 and 232 of the Companies Act, 2013. The order was pronounced on July 17, 2025, with an Appointed Date of March 31, 2024. Upon the scheme becoming effective (after filing the certified order with the Registrar of Companies), Ind-Swift Limited will stand dissolved without winding up. This is in continuation of an earlier intimation dated May 29, 2025, meaning the merger process has now cleared its key regulatory hurdle.
This is a positive structural development for shareholders as the amalgamation moves closer to completion, consolidating the Ind-Swift group's businesses into the listed entity. Shareholders should expect further updates on the effective date and any share-swap ratio, but no immediate impact on share price is expected until the scheme formally becomes effective.